http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106831927-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 |
| filingDate | 2017-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106831927-B |
| titleOfInvention | A kind of synthetic method of Astragaloside IV |
| abstract | The invention discloses a kind of synthetic method of Astragaloside IV, comprise the following steps：By 3 of cycloastragenol and 6 hydroxyls with protection group R 1 Protection；16 and 25 hydroxyls are with protection group R 2 3 and 6 protection group R are removed after protection 1 , obtain compound 4；By 3 hydroxyls of compound 4 with protection group R 3 Protection, obtains compound 5；Compound 5 is subjected to glycosylation reaction, removes 3 protection group R afterwards 3 , continue that glycosylation reaction occurs, obtain compound 8；All protection group removings, obtain Astragaloside IV；High-efficiency high-stereoselectivity of the present invention is prepared for Astragaloside IV, fills up the blank of prior art, will promote activity mechanism research and its process of drug development of Astrageloside compound significantly. |
| priorityDate | 2017-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.